Skip to main content
. Author manuscript; available in PMC: 2010 Dec 1.
Published in final edited form as: J Neurooncol. 2009 Jun 17;95(3):393–400. doi: 10.1007/s11060-009-9937-x

Table 2.

Toxicitiesa

Adverse event Grade 3 Grade 4 Grade 5 Grade 3 or 4




Number of patients % Number of patients % Number of patients % Number of patients %
Total toxicities 6 14 7 17 2 5 15 36
Hematologic 6 14 6 14 12 29
 Anemia 1 2 1 2
 Neutropenia 5 12 6 14 11 26
 Leukopenia 3 7 4 10 7 17
 Thrombocytopenia 4 10 4 10 8 19
Non-Hematologic 4 10 4 10 2 5 10 24
 Gastrointestinal 4 10 3 7 7 17
  Diarrhea 4 10 4 10
  Dehydration 1 2 1 2 2 5
  Colitis/typhlitis 2 5 2 5
 Infection 1 2 3 7 4 10
 Pulmonary 2 5 2 5
  Pneumonitis/pulm. inf. 1 2 1 2
  ARDS 1 2 1 2
 Thrombosis 1 2 2 5 3 7
 Hypotension 1 2 1 2 2 5
 ALT 1 2 1 2
 Renal failure 1 2
 Cerebral CNS hemorrhage 1 2

ALT alanine transaminase, ARDS acute respiratory distress syndrome, CNS central nervous system, pulm. Inf., pulmonary infiltrates

a

Some patients had more than one type of toxicity, and totals therefore may exceed 42